Esculaap4.svg
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.


Cytochroma P450 CYP2C9 (-atis, n.) (Numerus EC: 1.14.13.48) est haemoproteinum et pars gregis cytochromatum P450.

Cytochroma P450 CYP2C9.

Natura structuraque biochemicaRecensere

Cytochroma P450 CYP2C9 est et polypeptidum et haemoproteinum, quod ex 490 acidis aminicis (massa 55.628 Da) constitutum est. Intra cellulam enzymum hoc in ancoris membranae stat[1].

GeneticaRecensere

Nomen geni cytochromatis est CYP2C9 locus cuius geneticus in chromosomate 10 humano locatus est (10q23.33).

Pharmaca ad CYP2C9 relataRecensere

Pharmaca relata ad CYP2C9[2][3].
Substrati Inhibitores[4] Inductores[5]
  • Rifampicinum (forte)
  • Secobarbitalum (forte)
  • Phenobarbitalum

NotaeRecensere

  1. Cojocaru V, Balali-Mood K, Sansom MS, Wade RC (2011). "Structure and dynamics of the membrane-bound cytochrome P450 2C9". PLoS Comput Biol 7 (8): e1002152 
  2. Cozza KL, Armstrong SC (2001). The Cytochrome P450 System. Drug Interaction Principles for Medical Practice. Washington, DC: American Psychiatric Publishing
  3. Preskorn SH (1996). Clinical Pharmacology of Selective Serotonin Reuptake Inhibitors. 1st ed.: Professional Communications, Inc.
  4. Inhibitor cum subtratorum effectibus fortioribus
  5. Inductor cum subtratorum effectibus minoribus
  6. Berka K, Hendrychová T, Anzenbacher P, Otyepka M (2011). "Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site". J Phys Chem A 115 (41): 11248-55 

Nexus externiRecensere